Ranger Biotechnologies A/S: Financial statements 2017
CVR: 32280404
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,274,000 and a net result of DKK -4,850,000 compared with DKK 1,520,000 the year before. Equity in the 2017 report amounted to DKK 14,346,000. The solvency ratio was 94.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,274,000
- Profit/Loss
- DKK -4,850,000
- Equity
- DKK 14,346,000
- Total Assets
- DKK 15,155,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -1.3M | -4.9M | 14.3M | 1 |
| 2016 | - | 2.1M | 1.5M | 5.9M | 1 |
| 2015 | - | -733K | -633K | 4.4M | 1 |
| 2014 | - | -1.2M | -1.3M | 4.7M | 1 |
| 2013 | - | -699K | -1.1M | 6M | 1 |
Official annual report
Keep an eye on Ranger Biotechnologies A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 23, 2017, Peter Buhl has joined the board of directors of Ranger Biotechnologies A/S.
As of October 23, 2017, Jarne Elleholm has joined the board of directors of Ranger Biotechnologies A/S.
As of October 23, 2017, Finn Cilius Nielsen has left the board of directors of Ranger Biotechnologies A/S.
As of October 22, 2017, Peter Buhl has left the board of directors of Ranger Biotechnologies A/S.
Ranger Biotechnologies A/S has published its annual report for 2016. Gross profit came to DKK 2,138,000, and the net result was DKK 1,520,000.
About Ranger Biotechnologies A/S
Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.